Journal of Dermatological Science
Volume 60, Issue 1 , Pages 45-47 , October 2010

Circulating level of chemerin is upregulated in psoriasis

  • Shigetoshi Sano

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +81 88880 2363; fax: +81 88880 2364.

Received 13 May 2010

References 

  1. Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, Madonna S, et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med. 2009;206:249–258
  2. Wang Y, Chen J, Zhao Y, Geng L, Song F, Chen HD. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol. 2008;158:1134–1135
  3. Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Ishida-Yamamoto A, Izuka H. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol. 2008;159:1207–1208
  4. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters. 2008;582:573–578
  5. Kaur S, Zilmer K, Kairance C, Kals M, Zilmer M. Clear differences inn adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis. Br J Dermatol. 2008;159:1364–1367
  6. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med. 2008;205:767–775
  7. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol. 2009;161:339–344

PII: S0923-1811(10)00235-5

doi: 10.1016/j.jdermsci.2010.07.013

Journal of Dermatological Science
Volume 60, Issue 1 , Pages 45-47 , October 2010

Article Tools

* Image Usage & Resolution